Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.

× No keyword cloud information.

9 in total

1. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Authors: Jeffrey P Kahn; Leslie Meltzer Henry; Anna C Mastroianni; Wilbur H Chen; Ruth Macklin
Journal: Proc Natl Acad Sci U S A Date: 2020-10-29 Impact factor: 11.205

Review 2. COVID-19: vaccination problems.

Authors: Harald Brüssow
Journal: Environ Microbiol Date: 2021-05-14 Impact factor: 5.476

3. Standards of evidence for institutional review board decision-making.

Authors: David B Resnik
Journal: Account Res Date: 2020-12-08 Impact factor: 3.057

4. Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.

Authors: Nir Eyal; Tobias Gerhard; Brian L Strom
Journal: Vaccine Date: 2021-04-30 Impact factor: 3.641

Review 5. Development of leading first-generation vaccines against SARS-CoV-2.

Authors: Pin-Yu Perera; Liyanage P Perera
Journal: Microbes Infect Date: 2021-05-19 Impact factor: 2.700

Review 6. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.

Authors: Rafael Dal-Ré; Linda-Gail Bekker; Christian Gluud; Søren Holm; Vivekanand Jha; Gregory A Poland; Frits R Rosendaal; Brigitte Schwarzer-Daum; Esperança Sevene; Halidou Tinto; Teck Chuan Voo; Nadarajah Sreeharan
Journal: Lancet Infect Dis Date: 2021-05-18 Impact factor: 25.071

Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials.

1. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.

Review 2. COVID-19: vaccination problems.

3. Standards of evidence for institutional review board decision-making.

4. Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.

Review 5. Development of leading first-generation vaccines against SARS-CoV-2.

Review 6. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities.

7. Risk, benefit, and social value in Covid-19 human challenge studies: pandemic decision making in historical context.

8. Why is COVID-19 associated with mental illness?

9. Human models for COVID-19 research.